Clinical Outcomes of patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with nab-paclitaxel + carboplatin (nab-P/C) and solvent-based paclitaxel + carboplatin (sb-P/C) stratified by age and renal function: a retrospective analysis of a phase III trial.